Publications by authors named "R Ancona"
Objectives: The prognostic characteristics of lung point-of-care ultrasound (L-POCUS) to predict respiratory decompensation in patients with emerging infections remains unstudied. Our objective was to examine whether scored lung ultrasounds predict hypoxia among a nonhypoxic, ambulatory population of patients with COVID-19.
Methods: This was a diagnostic case-control study.
Context: Postintubation sedation is a critical intervention for patients undergoing mechanical ventilation. Research in the intensive care unit (ICU) and adult emergency department (ED) demonstrates that appropriate postintubation sedation has a significant impact on patient outcomes. There are minimal published data regarding postintubation sedation for pediatric ED patients.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to find environmental features linked to higher rates of drug-related fatalities and created a risk score based on these features.
- Researchers analyzed overdose data from St. Louis County, using Risk Terrain Modeling (RTM) to determine how proximity to various places affected overdose risk, separating data by drug type and race of decedents.
- Key findings revealed that fatalities were notably higher near hotels/motels, foreclosures, and restaurants, with specific patterns differing by race, suggesting that certain built environments reflect social conditions that contribute to overdose risk.
Article Synopsis
- The SQuID protocol, aimed at treating low- to moderate-severity diabetic ketoacidosis outside of intensive care, was assessed for acceptability among emergency department and inpatient clinicians through a survey conducted between March and November 2023 at an urban academic hospital.
- A high response rate of 80% (107 out of 133 clinicians) revealed that 65% of ED clinicians preferred SQuID over traditional intravenous insulin, with overall acceptability rated positively across various domains.
- Clinicians expressed strong support for SQuID, describing it as easy to use and demonstrating a favorable attitude towards its implementation in clinical practice.
Objective: We previously demonstrated safe treatment of low- to moderate-severity (LTM) diabetic ketoacidosis (DKA) using the SQuID protocol (subcutaneous insulin in DKA) in a non-intensive care unit (ICU) observation setting, with decreased emergency department length of stay (EDLOS). Here, we expand eligibility to include sicker patients and admission to a regular medical floor and collected more detailed clinical data in a near-real-time fashion.
Methods: This is a real-world, prospective, observational cohort study in an urban academic hospital (March 4, 2023-March 4, 2024).